Stock 4569 KYORIN PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages KYORIN Pharmaceutical Co., Ltd.

Equities

4569

JP3247090008

Market Closed - Japan Exchange
Other stock markets
 11:30:00 07/06/2024 am IST 		5-day change 1st Jan Change
1,657 JPY +0.18% Intraday chart for KYORIN Pharmaceutical Co., Ltd. -3.38% -6.91%
2023 ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan MT
2021 KYORIN Holdings, Inc.(TSE:4569) dropped from S&P Japan 500 CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ATyr Pharma to Obtain $10 Million in Milestone Payment After Partner Starts Dosing Patients in Lung Disease Study in Japan
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2019; Provides Consolidated Earnings Guidance for the Fiscal Year 2020 Ending March 31, 2020; Announces Dividend for the Second Quarter Ended September 30, 2019, Payable on December 3, 2019; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2020
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2018; Provides Earnings for the First Half and Full Year of Fiscal Year Ending March 31, 2019
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Nine Months Ended December 31, 2017; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2018
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Six Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending March 31, 2018; Announces Dividend for the Second Quarter Ended September 30, 2017, Payable on December 4,2017; Provides Dividend Forecast for the Fiscal Year Ending March 31, 2018
KYORIN Holdings, Inc. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2017; Provides Consolidated Earnings Guidance for the First Half of Fiscal Year 2018 and Year Ending March 31, 2018; Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2018
KYORIN Holdings, Inc. Announces Consolidated Earnings Results for the Full Year Ended March 31, 2017; Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending March 31, 2018
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4569 Stock
  4. News KYORIN Pharmaceutical Co., Ltd.
  5. Other languages